Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All budesonide studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchBudesonideBudesonide (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients

Singh et al., American Journal of Otolaryngology, doi:10.1016/j.amjoto.2020.102892
May 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Budesonide for COVID-19
19th treatment shown to reduce risk in April 2021
 
*, now with p = 0.0000011 from 15 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,700+ studies for 94 treatments. c19early.org
Prospective study of 120 COVID-19 patients in India showing significant improvements in smell and taste with fluticasone nasal spray and triamcinolone oral paste. In the treatment group, smell and taste significantly improved by day 5 compared to day 1, while the control group showed no improvement or worsening of smell and taste by day 5.
Singh et al., 31 May 2021, prospective, India, peer-reviewed, mean age 50.9, 3 authors, study period June 2020 - November 2020. Contact: cheer7us@hotmail.com.
This PaperBudesonideAll
The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients
Chandra Veer Singh, Shraddha Jain, Sana Parveen
American Journal of Otolaryngology, doi:10.1016/j.amjoto.2020.102892
Background: To study the outcome of fluticasone nasal sprays in smell disorders and triamcinolone paste in taste dysfunction in a population of laboratory-confirmed SARS-CoV-2 patients as the test group. The control group will not be given any intervention and only monitoring of these symptoms will be done to compare the recovery time. Methods: This prospective interventional study was conducted from June to Nov 2020 at, Datta Meghe University during the COVID-19 outbreak. The 120 enrolled patients were tested at days 1 and 5 after proven infection by RT-PCR test. Result: The mean age for all cases is 50.88 ± 15.93 years, whereas for the controls mean age is 51.2 ± 14.89. 2. Among cases 45 (75%) were males and 15 (25%) were females, among controls 43 (71.66%) were males and 17 (28.33%) were females. Among the case group, after the use of fluticasone spray in the nose and triamcinolone paste in the mouth there was a statistically significant improvement in recognizing all the odours and taste on day 5 compared to day 1. On comparing the smell and taste of cases and control group, either there is no improvement or worsening in smell or taste on day 5 in the control group. Conclusion: The use of fluticasone nasal spray and triamcinolone paste had immensely influenced the basic senses such as smell and taste. Our study showed that olfactory and taste function significantly improved in patients with COVID-19. For all anosmia and dysgeusia cases who received fluticasone nasal spray and triamcinolone medications the recovery of smell senses and the taste was within a week.
Declaration of competing interest None declared.
References
Agyeman, Chin, Landersdorfer, Liew, Ofori-Asenso, Smell and taste dysfunction in patients with COVID-19: a systematic review and metaanalysis, Mayo Clin Proc, doi:10.1016/j.mayocp.2020.05.030
Beltrán-Corbellini, Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case-control study, Eur J Neurol, doi:10.1111/ene.14273
Bourgeois, Bourgeois, Theories of olfaction: a review, Revista Interamericana de Psicologia
Carrillo-Larco, Fernandez, Anosmia and dysgeusia in COVID-19: a systematic review, Wellcome Open Res, doi:10.12688/wellcomeopenres.15917
Dell'era, Farri, Garzaro, Gatto, Valletti et al., Smell and taste disorders during COVID-19 outbreak: cross-sectional study on 355 patients, Head Neck, doi:10.1002/hed.26288
Ent, Guideline for management of covid-19 anosmia
Giacomelli, Pezzati, Conti, Bernacchia, Siano et al., Selfreported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study, Clin Infect Dis, doi:10.1093/cid/ciaa330
Lahiri, Ardila, COVID-19 pandemic: a neurological perspective, Cureus, doi:10.7759/cureus.7889
Lechien, Chiesa-Estomba, Siati, Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19):a multicenter European study, EurArchOtorhinolaryngol, doi:10.1007/s00405-020-05965-1
Lehrich, Goshtasbi, Raad, Ganti, Papagiannopoulos et al., Aggregate prevalence of chemosensory and sinonasal dysfunction in SARS-CoV-2 and related coronaviruses, Otolaryngol Head Neck Surg, doi:10.1177/0194599820929278
Lozada-Nur, Chainani-Wu, Fortuna, Sroussi, Dysgeusia in COVID-19: possible mechanisms and implications, Oral Surg Oral Med Oral Pathol Oral Radiol, doi:10.1016/j.oooo.2020.06.016
Paolo, Does COVID-19 cause permanent damage to olfactory and gustatory function?, Med Hypotheses, doi:10.1016/j.mehy.2020.110086
Printza, Constantinidis, The role of self-reported smell and taste disorders in suspected COVID 19, Eur Arch Otorhinolaryngol, doi:10.1007/s00405-020-06069-6
Ross, David, Neven, Kais, Status of the vibrational theory of olfaction, Front Phys, doi:10.3389/fphy.2018.00025
Seo, Lee, Mo, Lee, Rhee et al., Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray, Arch Otolaryngol Head Neck Surg, doi:10.1001/archotol.2009.141
Tong, Wong, Zhu, Fastenberg, Tham, The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and metaanalysis, Otolaryngol Head Neck Surg, doi:10.1177/0194599820926473
Walker, Cranial nerve I: the olfactory nerve
Yan, Faraji, Prajapati, Boone, Decode, Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms, Int Forum Allergy Rhinol
{ 'indexed': {'date-parts': [[2024, 7, 4]], 'date-time': '2024-07-04T11:20:58Z', 'timestamp': 1720092058989}, 'reference-count': 18, 'publisher': 'Elsevier BV', 'issue': '3', 'license': [ { 'start': { 'date-parts': [[2021, 5, 1]], 'date-time': '2021-05-01T00:00:00Z', 'timestamp': 1619827200000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2021, 5, 1]], 'date-time': '2021-05-01T00:00:00Z', 'timestamp': 1619827200000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-017'}, { 'start': { 'date-parts': [[2021, 5, 1]], 'date-time': '2021-05-01T00:00:00Z', 'timestamp': 1619827200000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-037'}, { 'start': { 'date-parts': [[2021, 5, 1]], 'date-time': '2021-05-01T00:00:00Z', 'timestamp': 1619827200000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-012'}, { 'start': { 'date-parts': [[2021, 5, 1]], 'date-time': '2021-05-01T00:00:00Z', 'timestamp': 1619827200000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-029'}, { 'start': { 'date-parts': [[2021, 5, 1]], 'date-time': '2021-05-01T00:00:00Z', 'timestamp': 1619827200000}, 'content-version': 'stm-asf', 'delay-in-days': 0, 'URL': 'https://doi.org/10.15223/policy-004'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2021, 5]]}, 'DOI': '10.1016/j.amjoto.2020.102892', 'type': 'journal-article', 'created': {'date-parts': [[2021, 1, 18]], 'date-time': '2021-01-18T05:33:18Z', 'timestamp': 1610947998000}, 'page': '102892', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 40, 'title': 'The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in ' 'COVID-19 patients', 'prefix': '10.1016', 'volume': '42', 'author': [ {'given': 'Chandra Veer', 'family': 'Singh', 'sequence': 'first', 'affiliation': []}, {'given': 'Shraddha', 'family': 'Jain', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sana', 'family': 'Parveen', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.amjoto.2020.102892_bb0005', 'unstructured': 'Bourgeois A.E, Bourgeois J.E; Theories of olfaction: a review; Texas A&M ' 'University. Revista Interamericana de Psicologia. 193. 196. [Google ' 'Search].'}, { 'issue': '3', 'key': '10.1016/j.amjoto.2020.102892_bb0010', 'doi-asserted-by': 'crossref', 'first-page': '344', 'DOI': '10.1016/j.oooo.2020.06.016', 'article-title': 'Dysgeusia in COVID-19: possible mechanisms and implications', 'volume': '130', 'author': 'Lozada-Nur', 'year': '2020', 'journal-title': 'Oral Surg Oral Med Oral Pathol Oral Radiol'}, { 'key': '10.1016/j.amjoto.2020.102892_bb0015', 'first-page': '1', 'article-title': 'Status of the vibrational theory of olfaction', 'volume': '6', 'author': 'Hoehn Ross', 'year': '2018', 'journal-title': 'Front Phys'}, { 'issue': '4', 'key': '10.1016/j.amjoto.2020.102892_bb0020', 'article-title': 'COVID-19 pandemic: a neurological perspective', 'volume': '12', 'author': 'Lahiri', 'year': '2020', 'journal-title': 'Cureus'}, { 'key': '10.1016/j.amjoto.2020.102892_bb0025', 'article-title': 'Does COVID-19 cause permanent damage to olfactory and gustatory ' 'function? [published online ahead of print, 2020 Jul 9]', 'volume': '143', 'author': 'Paolo', 'year': '2020', 'journal-title': 'Med Hypotheses'}, { 'issue': '7', 'key': '10.1016/j.amjoto.2020.102892_bb0030', 'doi-asserted-by': 'crossref', 'first-page': '1591', 'DOI': '10.1002/hed.26288', 'article-title': 'Smell and taste disorders during COVID-19 outbreak: cross-sectional ' 'study on 355 patients', 'volume': '42', 'author': 'Dell’Era', 'year': '2020', 'journal-title': 'Head Neck'}, { 'issue': '9', 'key': '10.1016/j.amjoto.2020.102892_bb0035', 'doi-asserted-by': 'crossref', 'first-page': '2625', 'DOI': '10.1007/s00405-020-06069-6', 'article-title': 'The role of self-reported smell and taste disorders in suspected COVID ' '19', 'volume': '277', 'author': 'Printza', 'year': '2020', 'journal-title': 'Eur Arch Otorhinolaryngol'}, { 'issue': '15', 'key': '10.1016/j.amjoto.2020.102892_bb0040', 'doi-asserted-by': 'crossref', 'first-page': '889', 'DOI': '10.1093/cid/ciaa330', 'article-title': 'Self-reported olfactory and taste disorders in patients with severe ' 'acute respiratory coronavirus 2 infection: a cross-sectional study', 'volume': '71', 'author': 'Giacomelli', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.amjoto.2020.102892_bb0045', 'doi-asserted-by': 'crossref', 'unstructured': 'Beltrán-Corbellini, Á et al. “Acute-onset smell and taste disorders in ' 'the context of COVID-19: a pilot multicentre polymerase chain reaction ' 'based case-control study.” Eur J Neurol, ' 'https://doi.org/10.1111/ene.14273. [22 Apr. 2020, doi:10.1111/ene.14273 ' '- Google Search].', 'DOI': '10.1111/ene.14273'}, { 'key': '10.1016/j.amjoto.2020.102892_bb0050', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.mayocp.2020.05.030', 'article-title': 'Smell and taste dysfunction in patients with COVID-19: a systematic ' 'review and meta-analysis', 'author': 'Agyeman', 'year': '2020', 'journal-title': 'Mayo Clin Proc'}, { 'issue': '1', 'key': '10.1016/j.amjoto.2020.102892_bb0055', 'doi-asserted-by': 'crossref', 'first-page': '3', 'DOI': '10.1177/0194599820926473', 'article-title': 'The prevalence of olfactory and gustatory dysfunction in COVID-19 ' 'patients: a systematic review and metaanalysis', 'volume': '163', 'author': 'Tong', 'year': '2020', 'journal-title': 'Otolaryngol Head Neck Surg'}, { 'key': '10.1016/j.amjoto.2020.102892_bb0060', 'unstructured': 'Taste and smell impairment in COVID-19: an AAO-HNS anosmia reporting ' 'tool-based comparative study. Otolaryngol Head Neck Surg - [Google ' 'Search].'}, { 'key': '10.1016/j.amjoto.2020.102892_bb0065', 'first-page': '1', 'article-title': 'Association of chemosensory dysfunction and COVID-19 in patients ' 'presenting with influenza-like symptoms', 'author': 'Yan', 'year': '2020', 'journal-title': 'Int Forum Allergy Rhinol'}, { 'issue': '1', 'key': '10.1016/j.amjoto.2020.102892_bb0070', 'doi-asserted-by': 'crossref', 'first-page': '156', 'DOI': '10.1177/0194599820929278', 'article-title': 'Aggregate prevalence of chemosensory and sinonasal dysfunction in ' 'SARS-CoV-2 and related coronaviruses', 'volume': '163', 'author': 'Lehrich', 'year': '2020', 'journal-title': 'Otolaryngol Head Neck Surg'}, { 'key': '10.1016/j.amjoto.2020.102892_bb0075', 'article-title': 'Olfactory and gustatory dysfunctions as a clinical presentation of ' 'mild- to- moderate forms of the coronavirus disease (COVID- 19):a ' 'multicenter European study', 'author': 'Lechien', 'year': '2020', 'journal-title': 'EurArchOtorhinolaryngol'}, { 'key': '10.1016/j.amjoto.2020.102892_bb0080', 'series-title': 'Clinical methods: the history, physical, and laboratory examinations', 'article-title': 'Cranial nerve I: the olfactory nerve', 'author': 'Walker', 'year': '1990'}, { 'key': '10.1016/j.amjoto.2020.102892_bb0085', 'doi-asserted-by': 'crossref', 'first-page': '94', 'DOI': '10.12688/wellcomeopenres.15917.1', 'article-title': 'Anosmia and dysgeusia in COVID-19: a systematic review', 'volume': '5', 'author': 'Carrillo-Larco', 'year': '2020', 'journal-title': 'Wellcome Open Res'}, { 'issue': '10', 'key': '10.1016/j.amjoto.2020.102892_bb0090', 'doi-asserted-by': 'crossref', 'first-page': '1000', 'DOI': '10.1001/archoto.2009.141', 'article-title': 'Treatment of postviral olfactory loss with glucocorticoids, Ginkgo ' 'biloba, and mometasone nasal spray', 'volume': '135', 'author': 'Seo', 'year': '2009', 'journal-title': 'Arch Otolaryngol Head Neck Surg'}], 'container-title': 'American Journal of Otolaryngology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S019607092030586X?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S019607092030586X?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2023, 1, 13]], 'date-time': '2023-01-13T20:57:12Z', 'timestamp': 1673643432000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S019607092030586X'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 5]]}, 'references-count': 18, 'journal-issue': {'issue': '3', 'published-print': {'date-parts': [[2021, 5]]}}, 'alternative-id': ['S019607092030586X'], 'URL': 'http://dx.doi.org/10.1016/j.amjoto.2020.102892', 'relation': {}, 'ISSN': ['0196-0709'], 'subject': [], 'container-title-short': 'American Journal of Otolaryngology', 'published': {'date-parts': [[2021, 5]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste ' 'in dysgeusia in COVID-19 patients', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'American Journal of Otolaryngology', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.amjoto.2020.102892', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2021 Elsevier Inc. All rights reserved.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '102892'}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit